Last quarter (Q2 2024), BioVie's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, BioVie's net income was $-8.40M. See BioVie’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	-	-	-	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 5.88M	$ 45.08M	$ 27.25M	$ 138.05M	$ 2.69M	$ 2.50M
Operating Income	$ -5.88M	$ -45.08M	$ -27.25M	$ -138.05M	$ -2.69M	$ -2.50M
Net Non Operating Interest Income Expense	$ -244.46K	$ -3.74M	$ -2.12M	$ -537.48K	$ -4.77M	$ 886.00
Other Income Expense	$ -2.06M	$ 1.44M	$ -3.29M	$ 8.34M	$ -9.21M	$ 51.40K
Pretax Income	$ -4.05M	$ -50.26M	$ -26.08M	$ -130.25M	$ -16.68M	$ -2.44M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -4.05M	$ -50.26M	$ -26.08M	$ -183.85M	$ -33.78M	$ -2.49M
Basic EPS	$ -0.94	$ -1.55	$ -1.06	$ -14.82	$ -6.85	$ -0.98
Diluted EPS	$ -0.94	$ -1.55	$ -1.06	$ -14.82	$ -6.85	$ -0.98
Basic Average Shares	$ 110.24M	$ 32.48M	$ 24.66M	$ 12.40M	$ 4.93M	$ 2.54M
Diluted Average Shares	$ 110.24M	$ 32.48M	$ 24.66M	$ 12.40M	$ 4.93M	$ 2.54M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 5.88M	$ 45.08M	$ 27.25M	$ 138.05M	$ 2.69M	$ 2.50M
Net Income From Continuing And Discontinued Operation	$ -34.15M	$ -50.26M	$ -26.08M	$ -130.25M	$ -16.68M	$ -2.44M
Normalized Income	$ -18.92M	$ -39.70M	-	$ -138.59M	$ -7.47M	$ -2.50M
Interest Expense	-	-	-	$ 559.46K	$ 4.77M	$ 273.00
EBIT	$ -3.13M	$ -45.96M	$ -23.92M	$ -129.69M	$ -11.90M	$ -2.44M
EBITDA	$ -3.00M	$ -45.56M	$ -23.59M	$ -129.46M	$ -11.67M	$ -2.21M

Currency in USD

BioVie Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing